Modulation of Behavioral Deficits and Neurodegeneration by Tannic Acid in Experimental Stroke Challenged Wistar Rats

Mol Neurobiol. 2017 Oct;54(8):5941-5951. doi: 10.1007/s12035-016-0096-8. Epub 2016 Sep 27.

Abstract

Oxidative stress and inflammatory responses play a critical contributing factor in cerebral ischemia and reperfusion, which lead to lipid peroxidation and neuronal dysfunction that may represent a target for therapeutic intervention. The present study was aimed to elucidate the neuroprotective effect of tannic acid (TA), a natural polyphenol with potential antioxidant and antiinflammatory properties on middle cerebral artery occlusion (MCAO) model in rats. To test this hypothesis, male Wistar rats were pretreated with TA (50 mg/kg b.wt.) and then subjected to 2-h MCAO followed by 22 h of reperfusion. After 2-h MCAO/22-h reperfusion, neurological deficit, infarct sizes, activities of antioxidant enzymes, cytokine level, histology, and immunohistochemistry were used to analyze the expression of glial fibrillary acidic protein (GFAP) in ischemic brain. The pretreatment of TA showed a marked reduction in infarct size, improved neurological function, suppressed neuronal loss, and downregulated the GFAP expression in MCAO rats. A significantly depleted activity of antioxidant enzymes and content of glutathione in MCAO group were protected significantly in MCAO group pretreated with TA. Conversely, the elevated level of thiobarbituric acid reactive species and cytokines in MCAO group was attenuated significantly in TA-pretreated group when compared with MCAO group. The results indicated that TA protected the brain from damage caused by MCAO, and this effect may thorough diminish the oxidative stress and inflammatory responses.

Keywords: Antioxidants; Cerebral ischemia; Inflammation; Neurobehavior; Neuroprotection; Oxidative stress.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology*
  • Antioxidants / pharmacology
  • Brain / drug effects*
  • Brain / pathology
  • Brain Ischemia / drug therapy*
  • Brain Ischemia / pathology
  • Disease Models, Animal
  • Infarction, Middle Cerebral Artery / chemically induced
  • Infarction, Middle Cerebral Artery / pathology
  • Male
  • Neuroprotective Agents / pharmacology
  • Oxidative Stress / drug effects
  • Rats, Wistar
  • Stroke / drug therapy*
  • Tannins / pharmacology*
  • Thiobarbituric Acid Reactive Substances / metabolism

Substances

  • Anti-Inflammatory Agents
  • Antioxidants
  • Neuroprotective Agents
  • Tannins
  • Thiobarbituric Acid Reactive Substances